Autori: Amdzic Ljiljana
| Naslov | Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment (Article) |
| Autori | Mandic Danijela Nezic Lana Amdzic Ljiljana Vojinovic Natasa Gajanin Radoslav Popovic Miroslav Djeri Jugoslav Todorovic-Balint Milena R Dumanovic Jelena  Milovanovic Zoran A Grujic-Milanovic Jelica D Skrbic Ranko Jacevic Vesna M
|
| Info | CANCERS, (2023), vol. 15 br. 16, str. - |
| Projekat | This article was performed within the framework of COST (European Cooperation in Science and Technology) Action CA17104 STRATAGEM-"New diagnostic and therapeutic tools against multidrug-resistant tumours". Moreover, this research was partially supported by [CA17104]; COST (European Cooperation in Science and Technology) Action [MFVMA01/23-25]; Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, Serbia [451-03-47/2023-01/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
     |
| Naslov | Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment (Article) |
| Autori | Mandic Danijela Nezic Lana Amdzic Ljiljana Vojinovic Natasa Gajanin Radoslav B Popovic Miroslav Djeri Jugoslav Todorovic-Balint Milena R Dumanovic Jelena Milovanovic Zoran A Grujic-Milanovic Jelica D Skrbic Ranko Jacevic Vesna M
|
| Info | CANCERS, (2023), vol. 15 br. 16, str. - |
| Projekat | COST (European Cooperation in Science and Technology) Action [451-03-47/2023-01/200015]; Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, Serbia; Ministry of Science, Technological Development and Innovation, Republic of Serbia; [CA17104] |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
